Friday - July 31, 2026
BMJ Group: Antihistamines Likely Offer No Meaningful Benefit for Eczema and May Increase Harms
July 31, 2026
LONDON, England, July 31 (TNSjou) -- BMJ Group issued the following news release about The BMJ on July 30, 2026:

* * *

Antihistamines likely offer no meaningful benefit for eczema and may increase harms

Review addresses longstanding uncertainty around antihistamines for eczema

Researchers advise against routine use and call for updated guidance

-

Adding oral antihistamines to existing eczema treatments is unlikely to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products